Clinical Trials Logo

Clinical Trial Summary

Infantile spasms (IS) are seizures associated with a severe infantile epileptic encephalopathy. Both cessation of spasms and electrographic response are necessary for the best neurodevelopmental outcomes. Adrenocorticotrophic hormone (ACTH), or prednisolone, or vigabatrin are considered the first-line treatment individually. However, ACTH expense and availability are the barriers in developing countries including Thailand. Vigabatrin, therefore, is the first recommended by Epilepsy Society of Thailand due to ACTH unavailability. Recently, combined steroid treatments (either ACTH or high dose prednisolone) with vigabatrin are superior in cessation of spasms compared to steroid treatment alone. Thus, this study is aimed to compare the efficacy of vigabatrin with high dose prednisolone combination therapy and vigabatrin alone.


Clinical Trial Description

Infantile spasms are recognized as epileptic encephalopathy which include the hypsarrhythmia or variants electroencephalographic (EEG) features and psychomotor regression. Various underlying conditions are associated with the infantile spasm included cerebral malformation, hypoxic ischemic encephalopathy, genetic disorders (Down syndrome), tuberous sclerosis complex (TSC), etc. Although vigabatrin has the evidence to use as the first line treatment for infantile spasm related with TSC. Adrenocorticotrophic hormone (ACTH), or high dose prednisolone, or vigabatrin are the first line treatment of IS in non-TSC. The effectiveness of ACTH versus high dose prednisolone question have not yet definitely answered. Furthermore, ACTH expense and availability are the barriers in developing countries including Thailand. Vigabatrin, therefore, is the first option of therapy recommended by Epilepsy Society of Thailand due to ACTH unavailability. Recently, combined steroid treatments (either ACTH or high dose prednisolone) with vigabatrin are superior in cessation of spasms compared to steroid treatment alone. Questions about the clinical cessation of IS and electrographic remission by combination treatment with vigabatrin and high dose prednisolone compare to vigabatrin alone have not fully elucidated. Thus, this study is aimed to compare the efficacy of vigabatrin with high dose prednisolone combination therapy and vigabatrin alone. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04302116
Study type Interventional
Source Queen Sirikit National Institute of Child Health
Contact Kullasate Sakpichaisakul, MD
Phone 66-2-354-8333
Email kullasate.s@rsu.ac.th
Status Recruiting
Phase N/A
Start date May 18, 2020
Completion date December 2026

See also
  Status Clinical Trial Phase
Terminated NCT03421496 - A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms Phase 3
Active, not recruiting NCT04727970 - Tricaprilin Infantile Spasms Pilot Study Phase 1
Active, not recruiting NCT05279118 - Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome Phase 2/Phase 3
Recruiting NCT04289467 - Treatment of Refractory Infantile Spasms With Fenfluramine Phase 2
Recruiting NCT06266234 - Characterization by Automated System on Infantile Spasmes
Completed NCT05538936 - The Effect of Spa and Massage on Babies on Colic Symptoms N/A
Suspended NCT03347526 - A Novel Approach to Infantile Spasms Phase 3
Recruiting NCT03876444 - Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms Phase 2/Phase 3